Jones, D. A., Mistry, P., Dalby, M., Fulton-Lieuw, T., Kong, A. H., Dunn, J., . . . Gray, A. M. (2020). Concurrent cisplatin or cetuximab with radiotherapy for HPV-positive oropharyngeal cancer: Medical resource use, costs, and quality-adjusted survival from the De-ESCALaTE HPV trial. Eur J Cancer.

Jones, David A., Pankaj Mistry, Matthew Dalby, Tessa Fulton-Lieuw, Anthony H. Kong, Janet Dunn, Hisham M. Mehanna, und Alastair M. Gray. "Concurrent Cisplatin or Cetuximab With Radiotherapy for HPV-positive Oropharyngeal Cancer: Medical Resource Use, Costs, and Quality-adjusted Survival From the De-ESCALaTE HPV Trial." Eur J Cancer 2020.

Jones, David A., et al. "Concurrent Cisplatin or Cetuximab With Radiotherapy for HPV-positive Oropharyngeal Cancer: Medical Resource Use, Costs, and Quality-adjusted Survival From the De-ESCALaTE HPV Trial." Eur J Cancer 2020.